Contact: Anne Doerr
anne_doerr@dfci.harvard.edu
617-632-5665
Dana-Farber Cancer Institute

Shuji Ogino, MD, PhD, Dana-Farber, Brigham and Women's Hospital

Caption: In a study by researchers at Dana-Farber Cancer Institute, aspirin therapy can extend the life of colorectal cancer patients whose tumors carry a mutation in a key gene.

Credit: Dana-Farber Cancer Institute

Usage Restrictions: None

Related news release: Gene mutation identifies colorectal cancer patients who live longer with aspirin therapy